THE FOUNDATION FOR AIDS RESEARCH
This organization has already been registered
Someone in your organization has already registered and setup an account. would you like to join their team?Profile owner : a************o@a***r.o*g
Mission Statement
amfAR is one of the world's leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested nearly $600 million in its programs and has awarded more than 3,500 grants to research teams worldwide. For 35 years, amfAR-supported research has led to the breakthroughs that have transformed the global AIDS response—from the development of protease inhibitors able to treat HIV to how to effectively prevent mother-to-child transmission of the virus. amfAR has been at the forefront of the biomedical research that has transformed HIV from a death sentence into a manageable disease. Now, we are at the forefront of the cure research that could end the global AIDS pandemic, once and for all.
About This Cause
About Our Work: -In just the last five years, amfAR has awarded cure-focused grants totaling more than $50 million to support research conducted by 300 scientists working at close to 100 institutions in 16 countries. -The amfAR Institute for HIV Cure Research at UCSF has launched a complex clinical trial that aims to ‘train’ the body to control the virus without the need for anti-HIV treatment. -amfAR is also a leader in cell and gene therapy approaches to a cure and has embarked on an ambitious study that aims to deliver the gene therapy tools directly into the body through injection. -We have brought in experts from outside the field of HIV cure research, such as bioengineers, and have applied new tools and technologies to cure research, including nanotechnology and protein “fingerprinting.” -In 2018 amfAR was the second largest funder of HIV cure research in the world after the U.S. National Institutes of Health, and the largest among philanthropic organizations. amfAR’s approach has revolutionized HIV research. Here are four keys that make our work so successful: 1) Strategic Investment: We act as research venture capitalists by investing in promising but untested ideas with breakthrough potential. 2) Agility: Unlike other grantmakers, we can quickly pivot to emerging scientific opportunities. We get funds out the door and into the lab in weeks, not years. 3) Collaboration: amfAR brings talented researchers from multiple fields and institutions to work closely together and share information, accelerating progress. 4) Diversity: amfAR is committed to exploring diverse approaches to a cure and includes women and people from nearly every continent in its clinical trials.